Please login to the form below

Not currently logged in
Email:
Password:

The Carlyle Group

This page shows the latest The Carlyle Group news and features for those working in and with pharma, biotech and healthcare.

Vectura board backs Philip Morris takeover bid over The Carlyle Group offer

Vectura board backs Philip Morris takeover bid over The Carlyle Group offer

Following last week’s report of the bidding war between British tobacco giant Philip Morris International (PMI) and US private equity firm The Carlyle Group, the board of directors at Vectura ... The Carlyle Group refused to improve on its final offer

Latest news

  • British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura British officials reportedly monitoring Philip Morris’ proposed acquisition of Vectura

    Vectura, which is developing inhaled drug delivery solutions for a number of diseases – including COVID-19 – previously received another acquisition offer from private equity group Carlyle in May. ... However, the company’s board has withdrawn

  • Philip Morris International to acquire inhaled drug company Vectura for $1.2bn Philip Morris International to acquire inhaled drug company Vectura for $1.2bn

    Vectura, which is developing inhaled drug delivery solutions for a number of diseases – including COVID-19 – previously received another acquisition offer from private equity group Carlyle in May. ... However, the company’s board has withdrawn

  • The M&A trend in pharma The M&A trend in pharma

    By moving the domicile of the (new) parent company of the group, the tax that would otherwise be payable on overseas profits under 'controlled foreign company' rules can be reduced. ... Following the Carlyle Group's $4bn acquisition of Johnson and Johnson

  • J&J sells diagnostics unit to private equity firm J&J sells diagnostics unit to private equity firm

    Ortho-Clinical Diagnostics acquired by the Carlyle Group. Johnson &Johnson has agreed to sell its clinical diagnostics business to private equity firm Carlyle Group for $4.15bn as it continues to ... Carlyle is reported to have been one of three

  • The Carlyle Group appoints Essner

    The Carlyle Group, a global private equity firm, has appointed former Wyeth CEO,  Robert Essner,  as senior advisor to its global healthcare group. ... The Carlyle Group, a global private equity firm, has appointed Robert Essner, former CEO and

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest Intelligence

  • Pharma deals during March 2014 Pharma deals during March 2014

    On the last day of the month Johnson &Johnson (J&J) agreed to accept the $4bn offer from The Carlyle Group, which was originally announced in January, to acquire its ... Large pharma activity. Several of the large pharma announced strategic transactions

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...